Beach Investment Counsel’s Novartis NVS Stock Holding History

Beach Investment Counsel’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$2.94M	Sell	26,347 -1,219	-4%	-$130K	0.43%	39
2024 Q4	$2.68M	Sell	27,566 -6,276	-19%	-$669K	0.36%	46
2024 Q3	$3.89M	Sell	33,842 -330	-1%	-$37.4K	0.48%	44
2024 Q2	$3.64M	Sell	34,172 -3,813	-10%	-$383K	0.45%	48
2024 Q1	$3.83M	Buy	37,985 +150	+0.4%	+$15.4K	0.47%	48
2023 Q4	$3.82M	Sell	37,835 -790	-2%	-$76.3K	0.47%	48
2023 Q3	$3.93M	Buy	38,625 +345	+0.9%	+$35K	0.49%	56
2023 Q2	$3.86M	Sell	38,280 -1,415	-4%	-$142K	0.46%	58
2023 Q1	$3.65M	Sell	39,695 -3,300	-8%	-$288K	0.49%	49
2022 Q4	$3.9M	Sell	42,995 -910	-2%	-$76.6K	0.49%	48
2022 Q3	$3.34M	Sell	43,905 -7,664	-15%	-$635K	0.47%	51
2022 Q2	$4.36M	Sell	51,569 -3,365	-6%	-$295K	0.55%	49
2022 Q1	$4.82M	Sell	54,934 -1,050	-2%	-$90.9K	0.51%	53
2021 Q4	$4.9M	Sell	55,984 -50	-0.1%	-$4.15K	0.65%	47
2021 Q3	$4.58M	Hold	56,034	–	–	0.43%	58
2021 Q2	$5.11M	Sell	56,034 -4,258	-7%	-$379K	0.46%	56
2021 Q1	$5.15M	Hold	60,292	–	–	0.46%	58
2020 Q4	$5.69M	Sell	60,292 -1,440	-2%	-$126K	0.54%	52
2020 Q3	$5.37M	Sell	61,732 -1,300	-2%	-$113K	0.63%	44
2020 Q2	$5.5M	Sell	63,032 -843	-1%	-$72.8K	0.74%	38
2020 Q1	$5.27M	Sell	63,875 -70	-0.1%	-$6.25K	0.88%	32
2019 Q4	$6.05M	Sell	63,945 -1,998	-3%	-$179K	0.67%	38
2019 Q3	$5.73M	Hold	65,943	–	–	0.66%	38
2019 Q2	$6.02M	Sell	65,943 -7,649	-10%	-$647K	0.69%	39
2019 Q1	$6.34M	Hold	73,592	–	–	0.71%	37
2018 Q4	$5.77M	Sell	73,592 -56	-0.1%	-$4.36K	0.7%	38
2018 Q3	$5.69M	Hold	73,648	–	–	0.56%	43
2018 Q2	$4.99M	Hold	73,648	–	–	0.52%	44
2018 Q1	$5.34M	Buy	73,648 +56	+0.1%	+$4.26K	0.56%	48
2017 Q4	$5.54M	Sell	73,592 -1,172	-2%	-$88.4K	0.54%	42
2017 Q3	$5.75M	Hold	74,764	–	–	0.6%	38
2017 Q2	$5.59M	Sell	74,764 -247	-0.3%	-$17.5K	0.57%	38
2017 Q1	$4.99M	Hold	75,011	–	–	0.54%	43
2016 Q4	$4.9M	Buy	75,011 +38,295	+104%	+$2.48M	0.56%	41
2016 Q3	$2.6M	Hold	36,716	–	–	0.3%	60
2016 Q2	$2.71M	Hold	36,716	–	–	0.32%	56
2016 Q1	$2.38M	Buy	36,716 +334	+0.9%	+$22.7K	0.27%	67
2015 Q4	$2.81M	Buy	36,382 +6,641	+22%	+$528K	0.32%	63
2015 Q3	$2.45M	Hold	29,741	–	–	0.3%	58
2015 Q2	$2.62M	Hold	29,741	–	–	0.26%	70
2015 Q1	$2.63M	Hold	29,741	–	–	0.24%	66
2014 Q4	$2.47M	Sell	29,741 -5	-0%	-$414	0.21%	74
2014 Q3	$2.51M	Sell	29,746 -111	-0.4%	-$8.98K	0.23%	69
2014 Q2	$2.42M	Sell	29,857 -252	-0.8%	-$19.8K	0.22%	71
2014 Q1	$2.29M	Sell	30,109 -1,629	-5%	-$119K	0.21%	68
2013 Q4	$2.29M	Sell	31,738 -551	-2%	-$38.3K	0.21%	70
2013 Q3	$2.22M	Sell	32,289 -4,465	-12%	-$295K	0.24%	65
2013 Q2	$2.33M	Buy	+36,754	New	+$2.39M	0.25%	61

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Beach Investment Counsel's NVS Position: Q1 2025 in Review

Beach Investment Counsel reduced its Novartis (NVS) stake by 4.4% in Q1 2025, selling an estimated $130K and leaving 26,347 shares worth $2.94M. The position accounts for 0.43% of the portfolio, ranked #39.

Beach Investment Counsel first reported a position in NVS in Q2 2013 and has held it in 48 quarters since. The position peaked at $6.34M in Q1 2019. 1,357 funds tracked by Wall St. Rank hold NVS as of Q1 2025.

Beach Investment Counsel held 26,347 shares of Novartis worth $2.94M as of Q1 2025.
Beach Investment Counsel sold 1,219 Novartis shares in Q1 2025, an estimated $130K.
Novartis made up 0.43% of Beach Investment Counsel's portfolio in Q1 2025, its #39 holding.
Beach Investment Counsel first reported a position in Novartis in Q2 2013 and has held it in 48 quarters since.
Beach Investment Counsel's Novartis position peaked at $6.34M in Q1 2019.
1,357 funds tracked by Wall St. Rank held Novartis as of Q1 2025.

Based on Beach Investment Counsel's 13F filing for Q1 2025, filed 14 Apr 2025.